<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1110939</article-id><article-id pub-id-type="publisher-id">OALibJ-130446</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Histopathological Profile of Germ Cell Tumors in Kinshasa: About a Series of 30 Cases at the University Clinics of Kinshasa and Review of the Literature
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibanda</surname><given-names>Mobando Noé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tacite</surname><given-names>Kpanya Mazoba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diallo</surname><given-names>Isombeko Bomane</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kisile</surname><given-names>Mikuo Olive</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Anatomy-Pathology, University Clinics of Kinshasa, Kinshasa, The Democratic Republic of Congo</addr-line></aff><aff id="aff2"><addr-line>Interdisciplinary Center for Research in Medical Imaging (CIRIMED), Kinshasa, The Democratic Republic of Congo</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>01</month><year>2024</year></pub-date><volume>11</volume><issue>01</issue><fpage>1</fpage><lpage>18</lpage><history><date date-type="received"><day>30,</day>	<month>October</month>	<year>2023</year></date><date date-type="rev-recd"><day>9,</day>	<month>January</month>	<year>2024</year>	</date><date date-type="accepted"><day>12,</day>	<month>January</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Context and objective: The term (Germ cell tumors) designates a polymorphic group of neoplasms all deriving from primordial germ cells in both sexes. They belong to the group of embryonal tumors. These tumors are frequently studied in gonadal locations. Given the paucity of literature on all of these tumors in our country, we initiated this study in order to clarify their epidemiological and histological profile. 
  Methods: Our study is descriptive, based on the archives of biopsies (blocks and slides) recorded in the laboratory of the pathological anatomy department of the University Clinics of Kinshasa. 
  Results: In the period of our study, 3168 cases of tumors were diagnosed among which 30 cases were germ cell tumors, with a frequency of 0.94%, the sex ratio of 0.5, the average age of 22 years, the standard deviation of 17.56 and the minimum age of 0 and maximum 71 years. The P-value was very significant (0.0015%) and the confidence interval for the mean is between 16 and 29 years old. The non-seminomatous histological subtype was the most represented (83.3% in both sexes). Benign teratoma was represented at 60% and gonadal locations 53% compared to 47% for extragonadal locations, where the sacrococcygeal location predominated with 36%. 
  Conclusion: TG is more frequent in gonadal locations, but our study shows a frequency of 47% of extragonadal locations, which is not negligible. This should challenge us to improve the diagnosis and management of TG.
 
</p></abstract><kwd-group><kwd>Germ Cell Tumors</kwd><kwd> Epidemiological and Histopathological</kwd><kwd> Kinshasa</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Embryonic tumors constitute a very heterogeneous group of tumors whose overall incidence is difficult to estimate due to the lack of comprehensive studies due to their low frequency; germ cell tumors are considered rare tumors [<xref ref-type="bibr" rid="scirp.130446-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref2">2</xref>] . But certain studies which approach them individually report that seminomatous germ cell tumors (TGS) and non-seminomatous germ cell tumors (TGNS) are rare but their incidence is increasing [<xref ref-type="bibr" rid="scirp.130446-ref2">2</xref>] and can reach up to more than 25% of genito tumors in pediatric urinary tract after Wilms tumor according to certain studies [<xref ref-type="bibr" rid="scirp.130446-ref3">3</xref>] .</p><p>The incidence varies throughout the world, with even a large geographical and ethnic variation: it is high in the Scandinavian countries, Switzerland, Germany and New Zealand, average in the United States and Great Britain, very low in Africa. In the USA, it remains low in African-Americans and high in the Caucasian population [<xref ref-type="bibr" rid="scirp.130446-ref4">4</xref>] . There is also a very wide variation in locations. These tumors are more frequent in gonadal locations and less in extra-gonadal locations. And even in those here, they are very rare in the ovaries compared to the testicular location which is more common [<xref ref-type="bibr" rid="scirp.130446-ref5">5</xref>] . These variations are also observed in other epidemiological and topographical parameters such as age, sex and others.</p><p>It should therefore be noted that the incidence of germ cell tumors peaks around the ages of 15 and 40 and represents up to 95% of testicular tumors [<xref ref-type="bibr" rid="scirp.130446-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref7">7</xref>] . Faced with a paucity of literature in our country and the fact that in our Department no study has addressed germ cell tumors overall, we initiated this study to determine the epidemiological and histopathological profile of germ cell tumors in CUK [<xref ref-type="bibr" rid="scirp.130446-ref7">7</xref>] with a view to identifying trends, reducing diagnostic errors and, above all, improving their management.</p><p>The term (Germ cell tumors) designates a polymorphic group of neoplasms all deriving from the primordial germ cell in both sexes [<xref ref-type="bibr" rid="scirp.130446-ref8">8</xref>] . They form a large group with blastematous tumors called “embryonal tumors”. These tumors certainly present common characteristics, but with great diversity in their topographical distribution, which makes this group one of the most complex. Germ cell tumors have a frequency inversely proportional to age, that is, their frequency decreases with age [<xref ref-type="bibr" rid="scirp.130446-ref9">9</xref>] . They are very often studied with pathologies of the gonads where they are more frequent although they have other extra gonadal locations such as the pineal gland, the mediastinum and the peritoneal region [<xref ref-type="bibr" rid="scirp.130446-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref11">11</xref>] .</p><p>Patients with TG can have a 5-year survival rate of 95% with good treatment [<xref ref-type="bibr" rid="scirp.130446-ref12">12</xref>] , which requires diagnosis and appropriate staging for better management. This is why in this work these tumors will be studied taking into account their common characteristics and their embryonic origin. Understanding germ cell tumors requires good embryological knowledge to better understand their origin and distribution.</p><p>In the DRC, few studies are available that have addressed the epidemiological and histopathological profile of germ cell tumors, hence the interest of our work. Our objective was to describe the epidemiological and histopathological aspects of germ cell tumors in the Pathological Anatomy laboratory of CUK.</p><sec id="s1_1"><title>1.1. Embryological Reminders</title><p>The genesis of embryonic tumors is attributable to primordial germ cells (PGC = primordial germ cells) intended to form gametes (spermatozoa and oocytes). These germinal cells are of epiblastic origin on the one hand and on the other the somatic or nourishing cells which will surround the germinal cells. These somatic cells constitute the somatic gonadal blastema, the exact origin of which remains debated. The most common hypothesis has them coming from at least three sources: the mesonephros, the local mesenchyme, and the coelomic epithelium [<xref ref-type="bibr" rid="scirp.130446-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref14">14</xref>] .</p><p>Thus by considering the path of migration of germinal cells from the yolk sac towards the lumbar region (10th dorsal vertebra), passing through the primitive intestine, the mesentery and the existence of undifferentiated gonad, we can easily understand the different Probable locations of germ cell tumors: yolk sac, testicles, ovaries, midline of the body, lumbar region, etc.</p></sec><sec id="s1_2"><title>1.2. Epidemiology of Embryonal Tumors</title><p>Embryonic tumors (ET) are uncommon in the general population, but their incidence remains high in children where they represent the second most common type of cancer in children and adolescents after leukemia. Few studies have been carried out on ET due to their rarity (around 400 cases/year diagnosed in people &lt; 15 years of age in mainland France) [<xref ref-type="bibr" rid="scirp.130446-ref1">1</xref>] . The histological type of childhood cancer is very particular since carcinomas, which represent the vast majority of adult tumors, are practically rare in children. In this case, in addition to leukemias and lymphomas which represent 45% of malignant conditions, we mainly find so-called embryonic tumors and then sarcomas more similar to adult tumors. Most studies address embryonal tumors separately, by system, age group such as in children or simply malignant tumors. A study showed a proportion of 4.7% and sex ratio M/F of 0.9 of embryonal tumors for all tumors of the nervous system of children, while extra-gonadal and extra-cranial germ cell tumors have a proportion of 0.9 and sex ratio M/F 0.2 and 1.1 and 0.2 for gonadal malignant germ cell tumors [<xref ref-type="bibr" rid="scirp.130446-ref15">15</xref>] . Others report a frequency of 1% - 5% of extra gonadal germ cell tumors out of all germ cell tumors [<xref ref-type="bibr" rid="scirp.130446-ref10">10</xref>] . Germ cell tumors represent 20% of ovarian tumors, occupying second place after epithelial tumors [<xref ref-type="bibr" rid="scirp.130446-ref16">16</xref>] . While they represent 3% to 15% of malignant ovarian tumors in East Asian countries [<xref ref-type="bibr" rid="scirp.130446-ref17">17</xref>] . Seminoma is the most common testicular germ cell tumor and often occurs between the ages of 15 and 35 years [<xref ref-type="bibr" rid="scirp.130446-ref18">18</xref>] .</p></sec><sec id="s1_3"><title>1.3. Germ Cell Tumors</title><sec id="s1_3_1"><title>1.3.1. Classification</title><p>Germ cell tumors can be classified according to topography, according to their grades (SIOP) and according to histological subgroups (WHO). Topographic classification: Intracerebral germ cell tumors, extragonadal and extracerebral germ cell tumors, intragonadal germ cell tumors, other tumors [<xref ref-type="bibr" rid="scirp.130446-ref15">15</xref>] . Germ cell tumors of gonadal location: Testicular and ovarian. Germ cell tumors of extra-gonadal location: Sacrococcygeal, mediastinal, vaginal, other locations [<xref ref-type="bibr" rid="scirp.130446-ref19">19</xref>] . Furthermore, the WHO classification is the reference classification and it regularly undergoes updates, including that of 2004, 2016 and now that of 2022 (5th edition) (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s1_3_2"><title>1.3.2. Morphological Study</title><p>1) Germinomas (Seminoma and Dysgerminomeovary )</p><p>Germinomas, formerly called seminomatous germ cell tumors (TGS), constitute the most common pure germ cell tumors of the testis, 44% of testicular tumors and 58% of all TG which represent 95% of testicular tumors overall. Age groups between 25 and 40 are the most affected. They constitute 80% of TG observed beyond 60 years of testis [<xref ref-type="bibr" rid="scirp.130446-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref22">22</xref>] .</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> WHO classification of testicular tumors 5th edition, 2022</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Germ cell tumors derived from germ cell neoplasia in situ</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >Non-invasive germ cell neoplasia</td><td align="center" valign="middle" >Germ cell neoplasia in situ</td></tr><tr><td align="center" valign="middle" >Specific forms of intratubular germ cell neoplasia</td></tr><tr><td align="center" valign="middle" >Gonadoblastoma</td></tr><tr><td align="center" valign="middle" >Germinoma family of tumors</td><td align="center" valign="middle" >Seminoma</td></tr><tr><td align="center" valign="middle"  rowspan="6"  >Non-seminomatous germ cell tumors</td><td align="center" valign="middle" >Embryonic carcinoma</td></tr><tr><td align="center" valign="middle" >Yolk sac tumor, postpubertal-type</td></tr><tr><td align="center" valign="middle" >Choriocarcinoma</td></tr><tr><td align="center" valign="middle" >Placental trophoblastic site tumor</td></tr><tr><td align="center" valign="middle" >Cystic trophoblastic tumor</td></tr><tr><td align="center" valign="middle" >Teratoma with somatic-type malignancy</td></tr><tr><td align="center" valign="middle" >Mixed germ cell tumors of the testis</td><td align="center" valign="middle" >Mixed germ cell tumors</td></tr><tr><td align="center" valign="middle" >Germ cell tumors of unknown type</td><td align="center" valign="middle" >Regressed germ cell tumors</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Germ cell tumors unrelated to germ cell neoplasia in situ</td><td align="center" valign="middle" >Spermatocytosis tumor</td></tr><tr><td align="center" valign="middle" >Teratoma, prepubertal type</td></tr><tr><td align="center" valign="middle" >Yolk sac tumor, prepubertal-type</td></tr><tr><td align="center" valign="middle" >Testucular neuroendocrine tumor, prepubertal type</td></tr><tr><td align="center" valign="middle" >Mixed teratoma and yolk sac tumor, prepubertal-type</td></tr></tbody></table></table-wrap><p>WHO classification 2022 [<xref ref-type="bibr" rid="scirp.130446-ref20">20</xref>] .</p><p>Macroscopy: the tumor presents the appearance of a single, well-circumscribed nodule or more or less confluent, homogeneous, pinkish-white or grayish, beige or creamy-white and firm nodules. Necrotic changes are unusual [<xref ref-type="bibr" rid="scirp.130446-ref22">22</xref>] .</p><p>Nucleolated nucleus, associated with lymphocytic stroma (T lymphocytes).</p><p>It is composed of large cells (15 to 25 mm) with a clear or discreetly eosinophilic cytoplasm, a large nucleus, with pale chromatin, containing one or more rarely 2 prominent nucleoli, presenting variable mitotic activity without prognostic implication.</p><p>The architecture is massive or cordial. A lymphocytic infiltrate is practically constant. It can take the form of lymphoid follicles with a germinal center or be accompanied by plasma cells and eosinophils. In approximately 50% of cases we can observe a granulomatous reaction, composed of clusters of epithelioid cells, but rarely multinucleated giant cells of the Langhans type. Syncytiotrophoblastic cells can be observed in approximately 20% of cases, without associated cytotrophoblastic contingent. This should not lead to the diagnosis of associated Choriocarcinoma [<xref ref-type="bibr" rid="scirp.130446-ref22">22</xref>] . Immunohistochemistry: Tumor cells express PLAP (placental alkaline phosphatase) and C-KIT. β-HCG is expressed by syncytiotrophoblastic cells which can be associated with it in certain cases. Pure seminomas are very sensitive to radiotherapy and chemotherapy.</p><p>2) Non-seminomatous germ cell tumors [<xref ref-type="bibr" rid="scirp.130446-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref20">20</xref>]</p><p>a) Embryonic carcinoma (EC)</p><p>It is part of non-seminomatous germ cell tumors and consists of embryonic masses at a still very poorly differentiated stage. From a macroscopic point of view, the EC sectors appear heterogeneous, poorly defined, made up of solid territories, areas of necrosis, hemorrhages and are very friable. Histologically, it is made up of cohesive groups of undifferentiated cells suggestive of carcinoma and of compact, adenoid or tubulo-papillary architecture. Vascular emboli are common. The stroma is not very specific, although there are often large necrotic foci. Immunohistochemically, these tumors are generally non-secreting, but the serum αFP level may be discreetly increased. This expression must, however, raise the question of an association with a yolk tumor (endodermal sinus tumor).</p><p>b) Yolk tumor</p><p>It presents the morphology of the endodermal sinus or the yolk sac. Ma croscopically, these are often encapsulated tumors, half-solid, half-cystic with hemorrhagic areas, variable volume, forming a honeycomb appearance, with a smooth external surface, gray/yellow in color with necrotic areas.</p><p>From the histological point of view, they are often encapsulated tumors, semi-solid, semi-cystic with hemorrhagic areas, variable volume, forming a honeycomb appearance, with a smooth external surface, gray/yellow in color with necrotic areas. Proliferation of clear cells with very atypical nuclei arranged in a network and forming papillary structures, associated with areas of microcystic appearance [<xref ref-type="bibr" rid="scirp.130446-ref23">23</xref>] . The presence of Schiller-Duval bodies which are endoluminal papillary formations, with hyaline globules (balls), reminiscent of the morphology of a fetal glomerulus, is decisive for the diagnosis.</p><p>Immunohistochemistry: Based on the secretion of alfa-feto-protein which is uniformly positive. The study of cytokeratin 7 (CK7) and epithelial membrane antigen (EMA) is negative and useful for the differential diagnosis with adenocarcinomas.</p></sec><sec id="s1_3_3"><title>1.3.3. Choriocarcinoma (CC)</title><p>This is a non-seminomatous germ cell tumor with trophoblastic differentiation. Macroscopy: very hemorrhagic solid tumor. It reproduces the structure of the placenta with bizarre non-cohesive cytotrophoblastic and syncytiotrophoblastic cells and interstitial hemorrhage, but does not present placental villi. It is a very aggressive tumor with pulmonary, hepatic and brain metastases… or even vaginal metastases for uterine CC. Immunohistochemistry: Beta-HCG (detected in serum and on histological section) has an orientation value. SALL 4 is the most sensitive and specific of CC.</p></sec><sec id="s1_3_4"><title>1.3.4. Teratoma</title><p>First described by Wilms in 1896. Etymologically, the word “dysembryoma” derives from the Greek word “embryo” meaning embryo and “dys” meaning difficulty. The suffix “ome” means body, tumor, and swelling. It is the non-semi-nomatous germ cell tumor with somatic differentiation, composed of tissue deriving from the three embryonic layers: ectoderm, endoderm and mesoderm [<xref ref-type="bibr" rid="scirp.130446-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref28">28</xref>] .</p></sec><sec id="s1_3_5"><title>1.3.5. Classification</title><p>Teratoma can be classified into several groups:</p><p>1) According to location: Gonadal teratomas are those of the testicle and ovary and are far more common, while the second includes axial, internal teratomas which are median or paramedian, and are represented by: Epiphyseal, mesocephalic teratomas; Mediastinal teratomas; retroperitoneal teratomas. External axial teratomas: are visible at birth and adhere to one end of the vertebral axis, in contact with the integuments. They are often bulky. They are found in the pharynx, neck, umbilical cord and sacrococcygeal level.</p><p>2) According to the macroscopic aspects: Cystic teratoma (dermoid cyst) and very often benign, with a more or less thin pearly wall containing a grayish pasty material and hairs. Solid teratoma is often malignant, made of irregular mass and heterogeneous content with necrotic-hemorrhagic rearrangement [<xref ref-type="bibr" rid="scirp.130446-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.130446-ref28">28</xref>] .</p><p>3) According to tissue heterogeneity:</p><p>Complex multi-tissue teratoma Simple single-tissue teratoma</p><p>4) According to the anatomoclinical behavior and the state of tissue maturity): Benign (mature) teratoma is the most common benign germ cell tumor of the ovary, formed of well-differentiated tissues made of cells which do not present atypia, and its secondary cancerization remains exceptional. It can be simple composed of a single tissue (epidermal cyst) or complex composed of several tissues (dermoid cyst). Malignant (immature) teratoma was first described in 1960 by Th&#252;rlbeck and Scully. It accounts for 3% of teratomas, 1% of all ovarian cancers, and 20% of malignant ovarian tumors of germ cell origin (immature teratoma) [<xref ref-type="bibr" rid="scirp.130446-ref24">24</xref>] . Contain immature, incompletely undifferentiated tissues resembling embryonic tissues (especially neuroepithelial and glial structures). It is classified according to Thurlbeck and Scully prognostic grade, modified by Norris and O’Conner to better guide management [<xref ref-type="bibr" rid="scirp.130446-ref24">24</xref>] .</p></sec><sec id="s1_3_6"><title>1.3.6. Mixed or Complex Germ Cell Tumors</title><p>Finally, mixed tumors consist of combinations in varying proportions of the above histological types. These are macroscopically heterogeneous tumors. They include a mixture of different histological types within the same tumor: Malignant Teratoma + Choriocarcinoma + Embryonic Carcinoma and Vitelline + Seminoma tumors.</p></sec></sec></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Type of Study and Period of Study</title><p>This is a retrospective descriptive study, based on the archives of biopsies (blocks and slides) recorded in the laboratory of the Department of Pathological Anatomy of the University Clinics of Kinshasa. Our study covered a period of 21 years, from January 2000 to December 2021.</p></sec><sec id="s2_2"><title>2.2. Study Sample</title><sec id="s2_2_1"><title>2.2.1. Population of Study Cases</title><p>From the CUK Pathological Anatomy laboratory registers, we listed all the cases of cancer received during the study period, while selecting the cases for which the diagnosis of germ cell tumor was retained. The use of registers, analysis request forms and analysis reports allowed us to identify the age, sex and histopathological diagnosis. We then brought together the slides and tissue blocks from the selected cases, already fixed and embedded in paraffin. For any case where the slides were damaged or not found, new histological sections were made on the corresponding blocks.</p></sec><sec id="s2_2_2"><title>2.2.2. Selection Criteria</title><p>Case inclusion criteria: Any block and slide for which the diagnosis of germ cell tumor was retained after rereading by at least two pathologists.</p><p>Criteria for non-inclusion of cases: Any block or slide with a diagnosis other than germ cell tumor.</p><p>Case exclusion criteria: Any biopsy where the block or slide was lost or of poor quality not allowing good histological analysis.</p></sec><sec id="s2_2_3"><title>2.2.3. Sample Size</title><p>Our sampling being exhaustive or without replacement, we considered all biopsies for which the diagnosis of germ cell tumor was retained and meeting our inclusion criteria. Our sample size was 30 cases who met the inclusion criteria and drawn from our study population of 3168 tumor cases.</p></sec></sec><sec id="s2_3"><title>2.3. Variables of Interest</title><p>Demographic parameters: age; gender;</p><p>Clinical parameters: collection site (organ); clinical information.</p><p>Pathological parameters: histological nature; histological type; under histological type.</p><p>Figures 1-7 illustrate the different pathological entities encountered during our study.</p></sec><sec id="s2_4"><title>2.4. Conduct of the Histological Examination</title><p>All specimens had been fixed in 10% formalin, dehydrated and cleared, embedded in paraffin, cut with a microtome at 3 - 5 microns and stained with EO. The general architecture of the tissues was observed at low magnification (&#215;4). To highlight tumor cells and clarify their histological type, we used medium and high magnifications (&#215;10 and &#215;40). The participation of connective fibers was highlighted using trichrome staining. The slides were read again using an OLYMPUS BX41 co-observation microscope. The final results were retained after rereading all the slides by two examiners as independent readers; in the event of discrepancy in the results, a third examiner was used. <xref ref-type="table" rid="table2">Table 2</xref> shows the materials used in this study.</p></sec><sec id="s2_5"><title>2.5. Statistical Analysis</title><p>The data were entered into an Excel spreadsheet, then exported into R software version 5.26 for processing and statistical analysis. Categorical or qualitative variables were described using frequency tables (simple or crossed). Dependencies or connections between qualitative variables were tested using the Chi-square association test or logistic regression. The central tendency and dispersion parameters were used to summarize the information from the quantitative variables. A nonparametric test was used when the assumptions for using a parametric test did not allow it. All tests were carried out at the 5% significance level, the p-value was preferred to confidence intervals for the significance of statistical differences.</p></sec><sec id="s2_6"><title>2.6. Ethical Consideration</title><p>Given its documentary nature, the study respected anonymity and did not require the prior consent of patients, given the usual practice of biopsies, operating specimens from the operating theater, paraffin blocks and archive slides.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Materials used</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="3"  >1. Materials</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >- Registers and data sheets - Anatomopathological reports - Data collection sheets - Slides carrying histological sections - Paraffin-embedded tissue blocks - Slides - Coverslips - Microtome - Oven - Hotplate - Water bath - Bins - Medical gloves - Pipettes - Eukitt aqueous glue - Fridge - OLYMPUS BX 41 co-observation microscope - Microscope trinocular with digital camera LEICA DMRB - HP laptop</td></tr><tr><td align="center" valign="middle"  colspan="3"  >2. Reagents and stains</td></tr><tr><td align="center" valign="middle" >Standard coloring</td><td align="center" valign="middle" >Special colors</td><td align="center" valign="middle" >Observation</td></tr><tr><td align="center" valign="middle" >Hematoxylin and Eosin</td><td align="center" valign="middle" >Trichrome</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >- Xylene - Ethanol - Methanol - İsopropanol - Hematoxylin - Eosin - Lithium carbonate - Alcohol-acid</td><td align="center" valign="middle" >Blue trichrome Green trichrome</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Frequency</title><p>In our study, 3168 cases of tumors were diagnosed among which 30 cases were germ cell tumors. N = 3168, n = 30. The frequency of germ cell tumors for our study is 0.94%.</p></sec><sec id="s3_2"><title>3.2. Sociodemographic Characteristics</title><p>The average age is 22 years with a standard deviation of 17.56 which shows us a strong dispersion around the average whose minimum age is 0 and the maximum is 71 years. The student test (t-test) shows that the p-value is very significant (0.001 &lt; 5%) and the confidence interval for the mean within the study population is between 16 and 29 years. The female gender was the most represented with more than 66.6% of cases. Sex ratio = Number of men/Number of women (Sex ratio = 10/20 = 0.5). The male/female sex ratio was 0.5, which shows a strong female predominance. We note a predominance of benign TG in women at 70% compared to 30% in men. On the other hand, we observe a perfect equality of 50% in both sexes for malignant TG. However, there is a 100% predominance of seminomatous TG subtypes in the male sex.</p></sec><sec id="s3_3"><title>3.3. Histopathological Aspects</title><p><xref ref-type="table" rid="table3">Table 3</xref> shows a predominance of benign TG in women at 70% compared to 30% in men. On the other hand, we observe a perfect equality of 50% in both sexes for malignant TG. However, there is a 100% predominance of seminomatous TG subtypes in the male sex.</p><p><xref ref-type="table" rid="table4">Table 4</xref> shows a predominance of benign TG with 60% of cases, while malignant TG 40% on the one hand and on the other hand, a predominance of non-seminomatous subtype at 83.3%.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of sex according to histological nature and histological subtype according to sex</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Histological nature</th><th align="center" valign="middle"  colspan="3"  >Histological subtype</th></tr></thead><tr><td align="center" valign="middle" >Benign</td><td align="center" valign="middle" >Clever</td><td align="center" valign="middle" >Mixed germinal</td><td align="center" valign="middle" >Non-seminomatous</td><td align="center" valign="middle" >Seminomatous</td></tr><tr><td align="center" valign="middle" >Women</td><td align="center" valign="middle" >14 (70%)</td><td align="center" valign="middle" >6 (50%)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >20 (80%)</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Man</td><td align="center" valign="middle" >4 (30%)</td><td align="center" valign="middle" >6 (50%)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5 (20%)</td><td align="center" valign="middle" >4 (100%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >18 (100%)</td><td align="center" valign="middle" >12 (100%)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >25 (100%)</td><td align="center" valign="middle" >4 (100%)</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of diagnoses according to histological nature and histological subtype</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Diagnostic</th><th align="center" valign="middle"  colspan="2"  >Histological nature</th><th align="center" valign="middle"  colspan="3"  >Histological subtype</th></tr></thead><tr><td align="center" valign="middle" >Benign</td><td align="center" valign="middle" >Clever</td><td align="center" valign="middle" >Mixed germinal</td><td align="center" valign="middle" >Non-seminomatous</td><td align="center" valign="middle" >Seminomatous</td></tr><tr><td align="center" valign="middle" >Embryonic carcinoma of the ovary</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Embryonic carcinoma of the right testicle</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Uterine choriocarcinoma</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Cervical choriocarcinoma</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Benign teratoma of the ovary</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Vaginal choriocarcinoma</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Seminoma</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Mature ovarian teratoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Benign cystic teratoma of the ovary</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Mature teratoma</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Mature multi-tissue teratoma</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Mature ovarian teratoma: dermoid cyst of the ovary</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Immature and cystic multi-tissue teratoma</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Mature sacrococcygeal teratoma</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Teratoma, embryonal carcinoma</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >18 (60%)</td><td align="center" valign="middle" >12 (40%)</td><td align="center" valign="middle" >1 (3.3%)</td><td align="center" valign="middle" >25 (83.3%)</td><td align="center" valign="middle" >4 (13.3%)</td></tr></tbody></table></table-wrap><p><xref ref-type="table" rid="table5">Table 5</xref> shows a predominance of benign TG and the non-seminomatous histological subtype in the age group from 0 to 10 years with 56% and 36% respectively.</p><p><xref ref-type="table" rid="table6">Table 6</xref> shows a slight predominance of gonadal localization of TG which represents approximately 53% of cases.</p><p><xref ref-type="table" rid="table7">Table 7</xref> shows that extragonadal TG is respectively more found in the sacrococcygeal region with 36% of cases.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of age groups according to nature and histological subtype</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >age range</th><th align="center" valign="middle"  colspan="2"  >HISTOLOGICAL NATURE</th><th align="center" valign="middle"  colspan="3"  >HISTOLOGICAL SUBTYPE</th></tr></thead><tr><td align="center" valign="middle" >benign</td><td align="center" valign="middle" >Clever</td><td align="center" valign="middle" >Mixed germinal</td><td align="center" valign="middle" >Non-seminomatous</td><td align="center" valign="middle" >Seminomatous</td></tr><tr><td align="center" valign="middle" >0 to 10 years</td><td align="center" valign="middle" >10 (56%)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >9 (36%)</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >11 to 20 years old</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >21 to 30 years old</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >31 to 40 years old</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >41 to 50 years old</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >50 years</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >4</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of cases according to TG locations</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Location</th><th align="center" valign="middle" >NOT</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Gonadal</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >53</td></tr><tr><td align="center" valign="middle" >Extragonadal</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >47</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Distribution of cases according to the extragonadal location</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Extragonadal location</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Intracranial</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >00</td></tr><tr><td align="center" valign="middle" >Mediastinal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Forearm</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Mesenteric (epiploic)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Sacrococcygeal</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >36</td></tr><tr><td align="center" valign="middle" >Uterine</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >21</td></tr><tr><td align="center" valign="middle" >Vaginal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Intestinal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Epidemiological Characteristics</title><p>Our study found a low frequency of TG of 0.94%. The sex ratio is (M/F = 0.5), which shows a predominance of females. Our results differ from those of Kripa Varghese et al. who found a M/F sex ratio of 1.22 [<xref ref-type="bibr" rid="scirp.130446-ref3">3</xref>] and Jankowski et al. 1.2 [<xref ref-type="bibr" rid="scirp.130446-ref15">15</xref>] . This can be explained by the fact that they studied urogenital tumors in children and adolescents for the first and the second all tumors of children and adolescents, while we considered TG in the general population.</p><p>The average age at the time of diagnosis was 22 years with a standard deviation of 17.5, which shows a strong dispersion around the average, the minimum age of which is 0 and the maximum is 71 years.</p><p>These results are similar to those of Nisrine Mamouni et al. [<xref ref-type="bibr" rid="scirp.130446-ref29">29</xref>] . Who found 22 years as the average age for malignant germ cell tumors, while this age for us is for malignant and benign TG.</p><p>They are a little closer to those of Cano Garcia et al., who found an average age of 28 years [<xref ref-type="bibr" rid="scirp.130446-ref30">30</xref>] . On the other hand, our results are different from those found by Bastos et al. and Monagel et al., who found respectively 30 years as the median age (study on testicular TG) [<xref ref-type="bibr" rid="scirp.130446-ref31">31</xref>] and 4.71 as the mean age in his (study on extracranial TG) [<xref ref-type="bibr" rid="scirp.130446-ref32">32</xref>] .</p><p>This difference could be explained for the first by the fact that he worked on testicular TG only, while the second studied TG in children aged 0 to 14 years. We also note that TG are not only the prerogative of the gonads, but gonadal locations represented 53% while extragonadal locations only 47%.</p><p>We found a male/female sex ratio of 0.5, which shows a strong female predominance. This result is contradictory with AB Effi et al. in Ivory Coast who found a sex ratio of 1.5 (male predominance) [<xref ref-type="bibr" rid="scirp.130446-ref33">33</xref>] . This can be explained by the fact that he worked on a large sample of 556 cases but above all that he worked on all solid tumors in children, leaving aside adults. These results also differ from Hsieh et al. who found a sex ratio of 1.09) [<xref ref-type="bibr" rid="scirp.130446-ref34">34</xref>] . This can be explained by the fact that his study focused on children.</p></sec><sec id="s4_2"><title>4.2. Histological Nature</title><p>Our study shows a predominance of benign TG overall with 60% and malignant TG with 40%. However, benign TG in females accounted for 70% compared to 30% in males. On the other hand, we observe a perfect equality of 50% in both sexes for malignant TG. However, there is a 100% predominance of seminomatous TG subtypes in the male sex.</p><p>These results are different from those found by Kripa Varghese et al. who found 13% of benign teratomas [<xref ref-type="bibr" rid="scirp.130446-ref3">3</xref>] . This can be explained by the fact that they studied urogenital tumors in children under 18 years of age, while we took into account all germ cell tumors in the general population.</p><p>The seminomatous subtype represented 13% in our study. These results are different from those found by Bastos et al. who found up to 47.1% of the seminoma subtype in their study on male TG in Brasilia [<xref ref-type="bibr" rid="scirp.130446-ref31">31</xref>] . This can be explained by the fact that they worked exclusively on male patients with a larger sample of 1232 subjects.</p></sec><sec id="s4_3"><title>4.3. The Location of TG</title><p>We found a predominance of TGs in the gonadal location at 53% and for extragonadal TGs the sacrococcygeal location predominates with 36%, while we did not find any intracranial locations (intracranial TGs 0%). These results are similar to those of Dania A et al. who found a predominance of gonadal TG while in extragonadal locations the sacrococcygeal region was the most found [<xref ref-type="bibr" rid="scirp.130446-ref32">32</xref>] .</p><p>These results differ from those of Jankowski M et al. who rather found a pre-dominance of intracranial TG and Hsieh et al. found a predominance of patients with intracranial TG in (53%) of cases [<xref ref-type="bibr" rid="scirp.130446-ref34">34</xref>] . This discrepancy can be explained by the larger sample size of the first (662 patients and a longer period of 31 years, compared to 30 cases in a period of 22 years for our study) but above all because of our limited means and difficult access to brain biopsies [<xref ref-type="bibr" rid="scirp.130446-ref15">15</xref>] .</p><p>De Felici M et al. reports frequencies of germ cell tumors ranging from 1% to 5% [<xref ref-type="bibr" rid="scirp.130446-ref10">10</xref>] . While our study shows up to 47% extragonadal localization of germ cell tumors, this clearly illustrates the variability of results on the subject.</p></sec></sec><sec id="s5"><title>5. Conclusions</title><p>TG are certainly rare tumors affecting the gonads, but intracranial and extracranial (extragonadal) locations are also well represented. Most studies address TG either in children or adults but in both sexes separately. Our study addresses the subject throughout the general population and shows the need to deepen the subject in all structures of our country. We recommend a good completeness of data registers and extend this study throughout the Democratic Republic of Congo.</p><p>Limitations of the study: The small sample size in our study and the absence of cases of intracranial TG, but especially the non-use of immunohistochemistry make this its weaknesses.</p><p>Strengths: Its strength is to be original and takes into account all TG in the general population (men, women, adults and children) by revealing a general trend overall.</p><p>Perspectives and wishes: We recommend a good filling of the data registers and to extend this study throughout the Democratic Republic of Congo by carrying out immunohistochemical and molecular biology analyses.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>We declare that we have no conflict of interest regarding our subject of study.</p></sec><sec id="s7"><title>Cite this paper</title><p>No&#233;, I.M., Mazoba, T.K., Bomane, D.I. and Olive, K.M. (2024) Histopathological Profile of Germ Cell Tumors in Kinshasa: About a Series of 30 Cases at the University Clinics of Kinshasa and Review of the Literature. Open Access Library Journal, 11: e10939. https://doi.org/10.4236/oalib.1110939</p></sec></body><back><ref-list><title>References</title><ref id="scirp.130446-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Awounou, D., Guissou, S., Lacour, B., Clavel, J. and Goujon, S. (2022) Variations saisonnières de l’incidence des tumeurs embryonnaires de l’enfant en France, 2000-2015. Rev Dépidémiologie Santé Publique, 70, S34.  
https://doi.org/10.1016/j.respe.2022.01.006</mixed-citation></ref><ref id="scirp.130446-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Carbonnaux, M., Vinceneux, A., Peyrat, P. and Fléchon, A. (2020) Actualités dans le traitement à la rechute des patients atteints de tumeurs germinales. Bulletin du Cancer (Paris), 107, 912-924. https://doi.org/10.1016/j.bulcan.2020.03.012</mixed-citation></ref><ref id="scirp.130446-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Varghese, K., Srivastava, V.M. and Manojkumar, R. (2022) Histopathological Study of Childhood Tumors of the Urogenital System. Asian Journal of Medical Sciences, 13, 219-226. https://doi.org/10.3126/ajms.v13i9.44644</mixed-citation></ref><ref id="scirp.130446-ref4"><label>4</label><mixed-citation publication-type="book" xlink:type="simple">Cussenot, O. (2006) Génétique des tumeurs germinales du testicule. In: Soussy, B.L.C., Eds., Cancer du testicule, Springer-Verlag, Paris, 37-43.  
http://link.springer.com/10.1007/2-287-31232-3_3  
&lt;br /&gt;https://doi.org/10.1007/2-287-31232-3_3</mixed-citation></ref><ref id="scirp.130446-ref5"><label>5</label><mixed-citation publication-type="book" xlink:type="simple">Flèchon, A. and Droz, J.P. (2006) Biologie des tumeurs germinales. In: Guastalla, J.-P. and Ray-Coquard, I., Eds., Les cancers ovariens, Springer-Verlag, Paris, 478-479.  
http://link.springer.com/10.1007/2-287-30921-7_35  
&lt;br /&gt;https://doi.org/10.1007/2-287-30921-7_35</mixed-citation></ref><ref id="scirp.130446-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Tourne, M., Radulescu, C. and Allory, Y. (2019) Tumeurs germinales du testicule: Caractéristiques histopathologiques et moléculaires. Bulletin du Cancer, 106, 328-341.  
https://doi.org/10.1016/j.bulcan.2019.02.004</mixed-citation></ref><ref id="scirp.130446-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Canete Portillo, S., Rais-Bahrami, S. and Magi-Galluzzi, C. (2022) Updates in 2022 on the Staging of Testicular Germ Cell Tumors. Human Pathology, 128, 152-160.  
https://doi.org/10.1016/j.humpath.2022.07.009</mixed-citation></ref><ref id="scirp.130446-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Roska, J., Lobo, J., Ivovic, D., Wachsmannová, L., Mueller, T., Henrique, R., et al. (2023) Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. International Journal of Molecular Sciences, 24, Article 2495.  
https://doi.org/10.3390/ijms24032495</mixed-citation></ref><ref id="scirp.130446-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Desandes, E. (2013) épidémiologie des cancers de l’adolescent. Revue d’Oncologie Hématologie Pédiatrique, 1, 15-20. https://doi.org/10.1016/j.oncohp.2013.04.002</mixed-citation></ref><ref id="scirp.130446-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">De Felici, M., Klinger, F.G., Campolo, F., Balistreri, C.R., Barchi, M. and Dolci, S. (2021) To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm. International Journal of Molecular Sciences, 22, Article 5982.  
https://doi.org/10.3390/ijms22115982</mixed-citation></ref><ref id="scirp.130446-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Holland, P., Karmas, E., Merrimen, J. and Wood, L.A. (2022) Accuracy of Germ Cell Tumor Histology and Stage within a Canadian Cancer Registry. Canadian Urological Association Journal, 17, 44-48. https://cuaj.ca/index.php/journal/article/view/8030  
https://doi.org/10.5489/cuaj.8030</mixed-citation></ref><ref id="scirp.130446-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Farnetani, G., Fino, M.G., Cioppi, F., Riera-Escamilla, A., Tamburrino, L., Vannucci, M., et al. (2023) Long-Term Effect of Cytotoxic Treatments on Sperm DNA Fragmentation in Patients Affected by Testicular Germ Cell Tumor. Andrology, 11, 1653-1661. https://doi.org/10.1111/andr.13429</mixed-citation></ref><ref id="scirp.130446-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Encha-Razavi, F. and Escudier, E. (2008) Embryologie Humaine. Elsevier Masson, Issy-les-Moulineaux.</mixed-citation></ref><ref id="scirp.130446-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Pawlina, W. and Ross, M.H. (2018) Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. 7th Edition, Lippincott Williams &amp; Wilkins, Philadelphia.</mixed-citation></ref><ref id="scirp.130446-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Jankowski, M., Dresse, M.F., Forget, P., Piette, C., Florkin, B. and Hoyoux, C. (2019) Epidémiologie des cancers de l’enfant, une étude monocentrique (1985-2016). Revue Médicale de Liège, 74, 146-151.  
https://orbi.uliege.be/handle/2268/238210</mixed-citation></ref><ref id="scirp.130446-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Bazot, M., Cortez, A. and Buy, J.N. (2004) Tumeurs a Cellules Germinales. Journal de Radiologie, 85, 1323. https://doi.org/10.1016/S0221-0363(04)77053-5</mixed-citation></ref><ref id="scirp.130446-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Akhavan, S., Agah, J. and Navipour, E. (2022) Different Clinical Presentations of Malignant Ovarian Germ Cell Tumors based on Age, Parity and Histology. Journal of Iranian Medical Council, 5, 580-588.  
https://publish.kne-publishing.com/index.php/JIMC/article/view/11330  
&lt;br /&gt;https://doi.org/10.18502/jimc.v5i4.11330</mixed-citation></ref><ref id="scirp.130446-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Itsa, N.A.I., Hadibrata, E. and Soleha, T.U. (2023) Etiology, Pathophysiology, Histopathology, and Diagnosis of Seminoma. Medical Profession Journal of Lampung, 13, 90-95.</mixed-citation></ref><ref id="scirp.130446-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Faure-Conter, C., Rocourt, N., Sudour-Bonnange, H., Vérité, C., Martelli, H., Patte, C., Frappaz, D. and Orbach, D. (2013) Les tumeurs germinales de l’enfant. Bulletin du Cancer, 100, 381-391. https://doi.org/10.1684/bdc.2013.1729</mixed-citation></ref><ref id="scirp.130446-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Moch, H., Amin, M.B., Berney, D.M., Compérat, E.M., Gill, A.J., Hartmann, A., et al. (2022) The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours. European Urology, 82, 458-468.  
https://doi.org/10.1016/j.eururo.2022.06.016</mixed-citation></ref><ref id="scirp.130446-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Smith, Z.L., Werntz, R.P. and Eggener, S.E. (2018) Testicular Cancer: Epidemiology, Diagnosis, and Management. Medical Clinics of North America, 102, 251-264.  
https://doi.org/10.1016/j.mcna.2017.10.003</mixed-citation></ref><ref id="scirp.130446-ref22"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Camparo</surname><given-names> P. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>Tumeurs Germinales: Données Histo-Pathologiques</article-title><source> European Urology Oncology</source><volume> 2</volume>,<fpage> 70</fpage>-<lpage>77</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.130446-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Even, C., Lhommé, C., Duvillard, P., Morice, P., Balleyguier, C., Pautier, P., et al. (2011) Tumeurs du sac vitellin de l’ovaire: Revue de la littérature. Bulletin du Cancer, 98, 963-975. https://doi.org/10.1684/bdc.2011.1387</mixed-citation></ref><ref id="scirp.130446-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bouzoubaa, W., Jayi, S., Alaoui, F.Z.F., Chaara, H. and Melhouf, M.A. (2017) Tératome immature de l’ovaire: A propos d’un cas. The Pan African Medical Journal, 27, Article 263. https://doi.org/10.11604/pamj.2017.27.263.6400</mixed-citation></ref><ref id="scirp.130446-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Bonasoni, M.P., Comitini, G., Barbieri, V., Palicelli, A., Salfi, N. and Pilu, G. (2021) Fetal Presentation of Mediastinal Immature Teratoma: Ultrasound, Autopsy and Cytogenetic Findings. Diagnostics, 11, Article 1543.  
https://doi.org/10.3390/diagnostics11091543</mixed-citation></ref><ref id="scirp.130446-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Zvizdic, Z., Jonuzi, A., Milisic, E., Vranic, S. and Herzegovina, A. (2023) A Long-Term Outcome of the Patients with Sacrococcygeal Teratoma: A Bosnian Cohort. Turkish Archives of Pediatrics, 58, 168-173.  
https://doi.org/10.5152/TurkArchPediatr.2023.22268</mixed-citation></ref><ref id="scirp.130446-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Noun, M., Ennachit, M., Boufettal, H., Elmouatacim, K. and Samouh, N. (2007) Tératome immature de l’ovaire avec gliomatose péritonéale. à propos d’un cas et revue de la littérature. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 36, 595-601. https://doi.org/10.1016/j.jgyn.2007.04.005</mixed-citation></ref><ref id="scirp.130446-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Rao, S., Rajeswarie, R.T., Chickabasaviah Yasha, T., Nandeesh, B.N., Arivazhagan, A. and Santosh, V. (2017) LIN28A, a Sensitive Immunohistochemical Marker for Embryonal Tumor with Multilayered Rosettes (ETMR), Is Also Positive in a Subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT). Child’s Nervous System, 33, 1953-1959. https://doi.org/10.1007/s00381-017-3551-6</mixed-citation></ref><ref id="scirp.130446-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Mamouni, N., Saadi, H., Erraghay, S., Bouchikhi, C. and Banani, A. (2015) Tumeurs rares de l’ovaire: A propos d’une série de 11 cas de tumeurs non épithéliales malignes de l’ovaire. The Pan African Medical Journal, 20, Article 174.  
https://www.ajol.info/index.php/pamj/article/view/114472  
&lt;br /&gt;https://doi.org/10.11604/pamj.2015.20.174.3446</mixed-citation></ref><ref id="scirp.130446-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Cano Garcia, C., Panunzio, A., Tappero, S., Piccinelli, M.L., Barletta, F., Incesu, R.B., et al. (2023) Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages. Medicina, 59, Article 451.  
https://doi.org/10.3390/medicina59030451</mixed-citation></ref><ref id="scirp.130446-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Bastos, D.A., Gongora, A.B.L., Dzik, C., Jardim, D.L., Piva, M., Carcano, F.M., et al. (2023) Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515). Clinical Genitourinary Cancer, 21, e104-e113. https://doi.org/10.1016/j.clgc.2022.11.004</mixed-citation></ref><ref id="scirp.130446-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Monagel, D.A., Tala, A., Arwa, A., Sereen, B., Ilana, H., Deena, H., et al. (2023) Clinical and Pathological Characteristics of Extra-Cranial Germ Cell Tumors: A 30-Year Single-Center Experience in Saudi Arabia. Saudi Medical Journal, 44, 498-499. https://doi.org/10.15537/smj.2023.44.5.20230070</mixed-citation></ref><ref id="scirp.130446-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Effi, A.B., Aman, N.A., Koffi, K.D., Kouyaté, M., Doukouré, B., N’Dah, K.J., et al. (2012) Cancers solides de l’enfant en C&amp;ocirc;te d’Ivoire: Etude de 556 cas. Journal Africain du Cancer, 4, 204-208. https://doi.org/10.1007/s12558-012-0222-4</mixed-citation></ref><ref id="scirp.130446-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Hsieh, M., Chen, H., Lee, C., Hung, G., Chang, T., Chen, S., et al. (2023) A Case Series and Literature Review on 98 Pediatric Patients of Germ Cell Tumor Developing Growing Teratoma Syndrome. Cancer Medicine, 12, 13256-13269.  
https://doi.org/10.1002/cam4.6017</mixed-citation></ref></ref-list></back></article>